CTBT (7-chlorotetrazolo[5,1-c]benzo[1,2,4]triazine) producing ROS affects growth and viability of filamentous fungi

FEMS Microbiology Letters

Volumn 328, Issue 2, 2012, Pages 138-143

  Culakova, Hana ^a   Dzugasova, Vladimira ^a   Gbelska, Yvetta ^a   Subik, Julius ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Antifungal agents; Aspergillus; Chemosensitization; Conidia germination; Oxidative stress

Indexed keywords

1,2,4 BENZOTRIAZINE DERIVATIVE; 7 CHLOROTETRAZOLO[5,1 C]BENZO[1,2,4]TRIAZINE; DICHLORODIHYDROFLUORESCEIN DIACETATE; ITRACONAZOLE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTHRODERMA GYPSEUM; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BOTRYTIS CINEREA; CHAETOMIUM GLOBOSUM; CLADOSPORIUM HEBARUM; CONCENTRATION RESPONSE; CONIDIUM; CONTROLLED STUDY; DRUG EFFICACY; EPICOCCUM NIGRUM; FILAMENTOUS FUNGUS; FUNGAL SPORE GERMINATION; FUNGAL VIABILITY; FUNGICIDAL ACTIVITY; FUNGUS; FUNGUS GROWTH; GROWTH INHIBITION; MYCELIUM; NONHUMAN; OXIDATIVE STRESS; PAECILOMUCES FARINOSUS; PENICILLIUM FUNICULOSUM; PENICILLIUM PURPUROGENUM; PRIORITY JOURNAL; RHIZOPUS ORYZAE; SCOPULARIOPSIS BREVICAULIS; TRICHODERMA VIRIDE;

ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; CULTURE MEDIA; FUNGI; GERMINATION; HYPHAE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPORES, FUNGAL; TRIAZINES;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDA ALBICANS; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 84857238352     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02491.x     Document Type: Article

References (25)

1. Batova M, Klobucnikova V, Oblasova Z, Gregan J, Zahradnik P, Hapala I, Subik J & Schüller C (2010) Chemogenomic and transcriptome analysis identifies mode of action of the chemosensitizing agent CTBT (7-chlorotetrazolo[5, 1-c]benzo[1, 2, 4]triazine). BMC Genomics 11: 153.
2. Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A & Monk BC (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22: 291-321.
3. Cernicka J, Kozovska Z, Hnatova M, Valachovic M, Hapala I, Riedl Z, Hajos G & Subik J (2007) Chemosensitisation of drug-resistant and drug-sensitive yeast cells to antifungals. Int J Antimicrob Agents 29: 170-178.
4. Delaveau T, Delahodde A, Carvajal E, Subik J & Jacq C (1994) PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol Gen Genet 244: 501-511.
5. Di Pietro A, Conseil G, Pérez-Victoria JM et al. (2002) Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 59: 307-322.
6. Espinel-Ingroff A, Arthington-Skaggs B, Iqbal N, Ellis D, Pfaller MA, Messer S, Rinaldi M, Fothergill A, Gibbs DL & Wang A (2007) Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J Clin Microbiol 45: 1811-1820.
7. Gulshan K & Moye-Rowley WS (2007) Multidrug resistance in fungi. Eukaryot Cell 6: 1933-1942.
8. Herrero E, Ros J, Belli G & Cabiscol E (2008) Redox control and oxidative stress in yeast cells. Biochim Biophys Acta 1780: 1217-1235.
9. Ibrahim AS, Edwards JE Jr, Fu Y & Spellberg B (2006) Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother 58: 1070-1073.
10. Izumikawa K, Takazono T & Kohno S (2010) Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance. Curr Opin Infect Dis 23: 584-589.
11. Khan MS, Malik A & Ahmad I (2011) Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Med Mycol 50: 33-42.
12. Kim JH, Mahoney N, Chan KL, Molyneux RJ, May GS & Campbell BC (2008) Chemosensitization of fungal pathogens to antimicrobial agents using benzo analogs. FEMS Microbiol Lett 281: 64-72.
13. Kim JH, Campbell BC, Mahoney N, Chan KL, Molyneux RJ & Balajee A (2010) Augmenting the activity of antifungal agents against aspergilli using structural analogues of benzoic acid as chemosensitizing agents. Fungal Biol 114: 817-824.
14. Kim SY, Ko YJ, Jung KW, Strain A, Nielsen K & Bahn YS (2011) Hrk1 plays both Hog1-dependent and -independent roles in controlling stress response and antifungal drug resistance in Cryptococcus neoformans. PLoS ONE 6: e18769.
15. Liu P, Luo L, Guo J, Liu H, Wang B, Deng B, Long CA & Cheng Y (2010) Farnesol induces apoptosis and oxidative stress in the fungal pathogen Penicillium expansum. Mycologia 102: 311-318.
16. Loeffler J & Stevens DA (2003) Antifungal drug resistance. Clin Infect Dis 36(suppl 1): S31-41.
17. Maschmeyer G, Haas A & Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67: 1567-1601.
18. Niimi K, Harding DR, Parshot R et al. (2004) Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother 49: 1256-1271.
19. Onishi J, Meinz M, Thompson J et al. (2000) Discovery of novel antifungal (1, 3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 44: 368-377.
20. Paulsen IT & Lewis K, (eds) (2002) Microbial Multidrug Efflux. Horizon Scientific Press, Norfolk, UK.
21. Prasad R, Panwar SL & Smriti (2002) Drug resistance in yeasts - an emerging scenario. Adv Microb Physiol 46: 155-201.
22. Sanglard D (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5: 379-385.
23. Shi JP, Zhang H, Zhang ZD, Zhang GH, Gao AL & Xiang SB (2011) Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. Chin J Integr Med 17: 499-504.
24. Subik J & Behun M (1974) Effect of bongkrekic acid on growth and metabolism of filamentous fungi. Arch Microbiol 97: 81-88.
25. Vazquez JA (2007) Combination antifungal therapy: the new frontier. Future Microbiol 2: 115-139.